Activist investor Starboard met with Pfizer last week. Here's what went down, according to the hedge fund's cofounder and CEO ...

Pfizer CEO Albert Bourla is in a tough spot as activist investor Starboard Value continues to call for a change in the ...

Activist investor Starboard Value is baring its teeth at Pfizer management, more openly going after CEO Albert Bourla’s job.

Despite that cash windfall, Pfizer has "dramatically underperformed its peers and the market since 2019," according to ...

The pharmaceutical company’s stock is relatively cheap, representing an opportunity for patient value investors.

Activist hedge fund Starboard Value's chief executive officer said on Tuesday that drugmaker Pfizer's board needs to hold ...

Starboard Value criticizes Pfizer's leadership for underperformance, citing a 50% stock decline and missed growth targets ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Barely three years since its coronavirus vaccine helped stem the pandemic, Pfizer’s stock has lost 50 percent of its value ...

Activist investor Starboard Value has sharpened its criticism of Pfizer Inc. (NYSE:PFE), holding the pharmaceutical giant’s management accountable for failing to deliver on its promises of ...

NEW YORK, Oct 22 (Reuters) - Activist hedge fund Starboard Value's chief executive officer said on Tuesday that drugmaker Pfizer's (PFE.N), opens new tab board needs to hold management accountable ...

Newcomers will be plugging into the stock while its forward-looking dividend yield stands at 5.8%. There's a decent chance ...